These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1375712)

  • 1. Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study.
    Alfurayh O; Sobh M; Buali A; Ali MA; Barri Y; Qunibi W; Taher S
    Nephrol Dial Transplant; 1992; 7(4):327-32. PubMed ID: 1375712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays.
    Fabrizi F; Raffaele L; Bacchini G; Guarnori I; Pontoriero G; Erba G; Locatelli F
    Nephrol Dial Transplant; 1993; 8(8):744-7. PubMed ID: 7692356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
    Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
    ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
    Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
    Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients.
    Mondelli MU; Smedile V; Piazza V; Villa G; Barbieri C; Gattarello G; Mancini F; Raimondo G
    Nephrol Dial Transplant; 1991; 6(7):480-3. PubMed ID: 1717892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult hepatitis C virus infection among haemodialysis patients.
    Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
    Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.
    Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H
    J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic significance of anti-HCV IgM in chronic hepatitis C viral infection].
    Wu H; Wang J; Lin X
    Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):42-5. PubMed ID: 7541329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver disease in dialysis patients with antibodies to hepatitis C virus.
    al-Wakeel J; Malik GH; al-Mohaya S; Mitwalli A; Baroudi F; el Gamal H; Kechrid M
    Nephrol Dial Transplant; 1996 Nov; 11(11):2265-8. PubMed ID: 8941588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers.
    Elisaf M; Tsianos E; Mavridis A; Dardamanis M; Pappas M; Siamopoulos KC
    Nephrol Dial Transplant; 1991; 6(7):476-9. PubMed ID: 1717891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM antibodies to hepatitis C virus and haemodialysis patients.
    Navarro JF; Teruel J; Mateos M; Ortuño J
    Nephrol Dial Transplant; 1994; 9(8):1211. PubMed ID: 7528362
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of hepatitis C virus (HCV) antibodies in haemodialysis patients.
    Vandelli L; Medici G; Savazzi AM; De Palma M; Lusvarghi E
    Arch Virol Suppl; 1992; 4():339-42. PubMed ID: 1333330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
    Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
    Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on hepatitis C virus infection in haemodialysis patients].
    Koda T; Tamura I; Ichimura H; Kurimura O
    Kansenshogaku Zasshi; 1992 Jan; 66(1):66-9. PubMed ID: 1328419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease.
    Knudsen F; Wantzin P; Rasmussen K; Ladefoged SD; Løkkegaard N; Rasmussen LS; Lassen A; Krogsgaard K
    Kidney Int; 1993 Jun; 43(6):1353-6. PubMed ID: 7686238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection: implications for infection control strategies in hemodialysis units.
    Oliva JA; Ercilla G; Mallafre JM; Bruguera M; Carrió J; Pereira BJ
    Int J Artif Organs; 1995 Feb; 18(2):73-7. PubMed ID: 7558399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-A, non-B hepatitis and elevated serum aminotransferases in renal transplant patients. Correlation with hepatitis C infection.
    Brunson ME; Lau JY; Davis GL; Scornik J; Howard RJ; Pfaff WW
    Transplantation; 1993 Dec; 56(6):1364-7. PubMed ID: 7506451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.